Results 251 to 260 of about 11,441,017 (408)

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

How Do Mental Health Nursing Students in the United Kingdom Experience Assessment Against the NMC Generic Standards of Proficiency? A Cross-Field Comparison. [PDF]

Int J Ment Health Nurs
Kenwright M, McCrorie C, Bye C, Awty P, Doherty D, Cromar-Hayes M.   +5 more
europepmc   +1 more source

THE RENAL EFFECTS OF URETHANE AND COLCHICINE IN ADULT RATS [PDF]

, 1951
S. E. Dicker
openalex   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

Diphtheria Immunization of Adults [PDF]

, 1942
H. M. Leete
openalex   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Transition services in 22q11 deletion syndrome: Hit or miss. [PDF]

Health Care Transit
Ayoub S, Meier S, Cytrynbaum C, Swillen A, Steiner LA, Carbyn H, Elger BS, De Clercq E.   +7 more
europepmc   +1 more source

CREATINE AND CREATININE METABOLISM IN THE NORMAL MALE ADULT STUDIED WITH THE AID OF ISOTOPIC NITROGEN

, 1948
Henry D. Hoberman, Ethan A.H. Sims, John H. Peters   +2 more
openalex   +1 more source

Mechanisms and Functional Implications of Adult Neurogenesis

Cell, 2008
Chunmei Zhao, Wei Deng, F. Gage
semanticscholar   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source